SalaryGuide
AboutPricingFor Employers

Marketing jobs

3 marketing jobs

Coloplast logo
6 hrs ago

Field Marketing Specialist

Coloplast

USA (On-site)Full time$98K/yr – $147K/yr
Coloplast logo
6 weeks ago

Director, Customer Experience Marketing

Coloplast

Minneapolis, MN (On-site)Full time$172K/yr – $256K/yr
Coloplast logo
3 months ago

Senior Marketing Manager

Coloplast

Minneapolis, MN (Hybrid)

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

3 jobs
Coloplast logo

Field Marketing Specialist

Coloplast

USA (On-site)

$98K/yr - $147K/yrIn-houseFull-timeMid level3+ years exp.
6 hrs ago
Coloplast logo

Director, Customer Experience Marketing

Coloplast

Minneapolis, MN (On-site)

$172K/yr - $256K/yrIn-houseFull-timeDirector/executive7+ years exp.
6 weeks ago
Coloplast logo

Senior Marketing Manager

Coloplast

Minneapolis, MN (Hybrid)

In-houseSenior level7+ years exp.
3 months ago
Coloplast logo
Coloplast

Field Marketing Specialist

USA (On-site)

$98K/yr – $147K/yrMid Level3+ years expFull time

Posted 6 hrs ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own the field marketing initiatives for Coloplast in assigned accounts, driving adoption of programs, coordinating training, tracking metrics, and partnering with therapy development specialists to advance patient awareness; oversee program activation, materials, and feedback loops across regions.

Job Description

Responsibilities

  • The Field Marketing Specialist is responsible for supporting the local awareness and adoption of Coloplast products through the deployment and execution of the Coloplast Marketing Programs and the within strategic accounts designed to drive patient awareness, education and advance movement through the patient journey. This person will work with strategic accounts and ancillary staff, to adopt and successfully implement the Coloplast Programs within their respective practices.
  • Major Areas of Accountability
  • Works with Therapy Development Specialists to understand predetermined target list of accounts.
  • Serves as a project manager to oversee adoption, implementation, site activation and ongoing follow up for specific marketing programs to the selected target list of accounts
  • Trains target account and ancillary support staff on roles and responsibilities of Coloplast programs to include, program logistics, call patterns, incoming call support, call transfers to key departments, surgery scheduling support, insurance verification and other offerings
  • Tracks and reports standardized program metrics to Marketing.
  • Develops and maintains relationships with HCPs and key practice or office staff.
  • Serves as a Marketing ambassador within the Area/Region assigned and assists with supporting local programs such as product launches, trade shows, and other HCP engagement events.
  • Assists with creation of marketing materials for upcoming program launch.
  • Tests new program materials and provides feedback to Marketing team.

Requirements

  • BA or BS degree
  • 3+ years of medical tech experience with proven success
  • Entry level field marketing skills required
  • Reporting, strategic planning and project management skills at account, regional and national level
  • Strong business acumen and analytical skills
  • Knowledge of current and new healthcare industry trends, technologies, competitors and in the market
  • Pro-active; high-performance and results orientation
  • Personifies Coloplast Mission, Values and Vision as well as Coloplast Leadership Principals
  • Willingness and ability to travel 40-50%.

Benefits

  • Health and Wellness: Comprehensive medical, dental, and vision insurance plans to keep you and your family healthy. Plus, access to company sponsored wellness programs and mental health resources, paid leave of absence for qualifying events and generous paid parental leave for both birthing and non-birthing parents.
  • Financial Security: A competitive 401(k) plan with company match that vest immediately, financial planning services to help you secure your future, and corporate discount programs for goods and services.
  • Work-Life Balance: Generous paid time off, flexible work hours, and flexible work arrangement options to help you balance your personal and professional life may be available.
  • Professional Development: Opportunities for continuous learning and career advancement through training programs, mentorship, and tuition reimbursement.
  • Recognition and Rewards: Recognition programs to celebrate achievements and contributions, including peer recognition, bonuses, awards, and special events.
  • Community and Culture: A supportive work environment where everyone feels valued, and has a sense of belonging.  Participate in team-building activities, volunteer opportunities, and company-sponsored events. Sustainability strategy that outlines our ambitions for how to run our company in a more sustainable way
  • Competitive Compensation: The compensation range for this position is $98,019 - $147,029. Actual compensation is influenced by a variety of factors including but not limited to skills, experience, qualifications, and geographic location. Hired candidates may be eligible to receive additional compensation in the form of bonuses and/or incentives.
Coloplast logo

Coloplast

3.7 Glassdoor

Coloplast develops products and services to make life easier for people with deeply personal and private medical conditions. These conditions are often associated with trauma and taboo. The more intimate the condition, the greater the requirement to come closer to customers, understand their world and develop solutions that are sensitive to their special needs. We call this intimate healthcare.Closeness to all customers makes this possible. We listen to better understand needs and respond by finding new ways to do things better together. We lead the way by bringing the best ideas first and fast to market in the form of medical devices and service solutions. Deeply private and personal medical conditions are our focus. Our passion to make a real difference to people’s lives is what drives and unites us. Our culture supports high ambitions and releases the full potential of our own people to achieve them. Our business includes Ostomy Care, Continence Care, Advanced Wound Care, Interventional Urology and Voice & Respiratory Care. We operate globally, employing more than 16,500 people.

Founded in 1957
Humlebæk, Capital Region of Denmark, DNK
9.9K employees (400 in marketing)
www.coloplast.com
70% recommend to a friend
88% CEO approval

Traffic Signals

Monthly Visitors
149.1K
Traffic Source Mix
Search
32.3%
Direct
44.9%
Referral
13.1%
Social
8%
Paid
1.3%

Headcount Trend

Current headcount: ~9.9K

Marketing Team

Marketing Team Size
400 (4% of company)
Median Tenure
4.5 years
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$1.3B
Last Raise
$1.3B
Post IPO Equity, 3 years ago

Funding History

  • Aug 2023
    Post IPO Equity • $1.3B

Recent News

Coloplast A/ S stock (DK0060448595): FDA clears Titan Prime implant for U.S. market
Jun 3, 2026 • AD HOC NEWS
Coloplast’s Next Generation Inflatable Penile Prosthesis Approved by the FDA – can help millions of men
Jun 3, 2026 • BioSpace
Coloplast’s Inflatable Penile Prosthesis Approved By FDA
Jun 3, 2026 • TradingView
Coloplast receives FDA clearance for next-generation penile implant
Jun 3, 2026 • MarketScreener
EFN issues buy rating for under-pressure Coloplast shares
May 28, 2026 • marketscreener.com
从算力到生产力:京东AI的价值公式
May 18, 2026 • donews
Coloplast Q2 2026 Earnings Call: Complete Transcript
May 12, 2026 • Benzinga.com
Coloplast A/S - Announcement no. 05/2026 - Interim Financial Report, H1 2025/26
May 12, 2026 • BioSpace
Coloplast Q2 profit misses as Kerecis impairment and outlook weigh
May 12, 2026 • Investing.com
Coloplast receives innovative technology contract from Vizient for Biatain silicone fit
May 1, 2026 • MarketScreener
Coloplast Receives Innovative Technology Contract from Vizient for Biatain® Silicone Fit
May 1, 2026 • GlobeNewswire
Coloplast cuts fiscal year guidance on Kerecis struggles
Apr 24, 2026 • Investing.com
Coloplast A/S - H1 2025/26 Earnings Release - Invitation for conference call on 12 May 2026 at 11:00 CEST
Apr 23, 2026 • BioSpace
New Clinical Data on Fish-Skin Grafts to Headline Kerecis Presence at SAWC Spring
Apr 8, 2026 • BioSpace
Coloplast names Gavin Wood as new CEO
Mar 5, 2026 • Investing.com
Antimicrobial Urinary Catheters Market is expected to reach US$ 2.56 Billion by 2033 | DataM Intelligence
Feb 25, 2026 • EIN Presswire
Anti-Biofilm Wound Dressing Market to Hit USD 1.82 Billion by 2033, Due to Increasing Antibiotic Resistance and Sophisticated Infection Control Solutions – SNS Insider
Jan 23, 2026 • GlobeNewswire
Garcia Garcia builds €110 million factory for Danish company Coloplast in Felgueiras
Dec 19, 2025 • Essential Business
Coloplast announces changes to Executive Leadership Team
Dec 18, 2025 • GlobeNewswire
Coloplast A/S Announces Directorate Changes
Dec 4, 2025 • MarketScreener
Coloplast A/S - Decisions at the Annual General Meeting 2025
Dec 4, 2025 • Coloplast A/S
Coloplast price target raised by DKK 15 at Morgan Stanley
Nov 5, 2025 • thefly.com
Coloplast A/S - Full-Year Financial Results 2024/25
Nov 4, 2025 • Coloplast A/S
Coloplast A/S Recommends Year-End Dividend
Nov 4, 2025 • MarketScreener
Coloplast A/S - Annual Report 2024/25 & Remuneration Report 2024/25
Nov 4, 2025 • BioSpace
Coloplast's Adjusted Operating Profit Matches Expectations
Nov 4, 2025 • MarketScreener
Coloplast A/S - Annual Report 2024/25 & Remuneration Report 2024/25
Nov 4, 2025 • Coloplast A/S
Will Coloplast A S (Common Stock) (CBH) stock outperform foreign stocks - July 2025 Analyst Calls & Fast Entry High Yield Tips
Nov 2, 2025 • newser.com
Will Coloplast A S (CBHD) stock profit from AI boom - Treasury Yields & Community Consensus Trade Signals
Nov 2, 2025 • newser.com
Why Coloplast A S (CBHD) stock is trending on social media - Market Activity Summary & Consistent Income Trade Recommendations
Oct 31, 2025 • newser.com
Will Coloplast A S (CBHD) stock profit from AI boom - July 2025 Decliners & AI Optimized Trading Strategy Guides
Oct 30, 2025 • newser.com
What analysts say about Coloplast A S CBHD stock - Market Depth Overview & Affordable Stock Picks
Oct 30, 2025 • earlytimes.in
Can Coloplast A S (Common Stock) (CBH) stock attract ESG investments - Earnings Summary Report & Free Community Consensus Stock Picks
Oct 30, 2025 • newser.com
Coloplast A (CLPBY) Price Target Decreased by 33.51% to 20.87
Oct 29, 2025 • Nasdaq
After A 50% Decline, Coloplast Might Finally Be Worth Buying (OTCMKTS:CLPBF)
Oct 29, 2025 • Seeking Alpha
Why Coloplast A S (Common Stock) (CBH) stock could break out in 2025 - Inflation Watch & Fast Entry Momentum Alerts
Oct 22, 2025 • newser.com
Coloplast (CPSE:COLO B) Valuation in Focus as Leadership Transition Signals New Strategic Direction
Oct 19, 2025 • simplywall.st
Analyst expects easier CEO hunt with Lars Rasmussen out of Coloplast's board
Oct 10, 2025 • medwatch.com
Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting
Oct 9, 2025 • GlobeNewswire
United States Wound Care Market Report 2025-2033: Key States Like California, Texas, New York, and Florida Highlight Diverse Regional Growth Driven by Demand for Advanced Wound Management Solutions
Sep 26, 2025 • Research and Markets
Renal Stents Market Growth Trends: US$2.08 Billion by 2033, Driven by CKD & Technological Advances | DataM Intelligence
Sep 26, 2025 • EIN Presswire
Philips in talks with US over probes of medical technology imports
Sep 25, 2025 • MarketScreener
European shares fall as losses in healthcare, industrials weigh
Sep 25, 2025 • MarketScreener
Elsa Goodsen Named 2025 Influential Women Honoree for Innovative, Purpose-Driven Leadership in Patient Care
Sep 24, 2025 • EIN Presswire
Mid-Urethral Sling Manufacturers: PVDF and P4HB Safer Materials versus Polypropylene
Sep 12, 2025 • EIN Presswire
Foley Catheters Market worth US$1,205.0 million by 2030 with 5.3% CAGR | MarketsandMarkets™
Sep 11, 2025 • PR Newswire UK
Kerecis Expands SurgiClose Silicone Fish-Skin Product Line with New Sizes for Smaller Wounds
Sep 9, 2025 • PharmiWeb
Deutsche Bank lowers Coloplast stock price target on margin concerns
Sep 8, 2025 • Investing.com
Skeptical fund buys into Coloplast after strategy change: It was a mistake to appoint Lars Rasmussen
Sep 8, 2025 • medwatch.com
Coloplast price target lowered by DKK 50 at Berenberg
Sep 8, 2025 • thefly.com
Berenberg Lowers Coloplast Price Target After New Five-year Strategy Update
Sep 5, 2025 • MarketScreener
Coloplast's CEO hunt continues: Board focuses on experience, culture match and results
Sep 4, 2025 • medwatch.com
Coloplast makes mass layoff in China: No mistake to invest heavily in the country, says CEO
Sep 3, 2025 • medwatch.com
Coloplast has wiped the slate clean with new strategy: Analysts eagerly await execution
Sep 3, 2025 • medwatch.com
Erectile Dysfunction Devices Market Anticipated to Grow to USD 10.5 Billion at 6.22% CAGR by 2035
Sep 3, 2025 • EIN Presswire
Ureteral Stents Market is Poised to Attain Valuation of US$ 685.05 Million by 2033 | Astute Analytica
Sep 3, 2025 • AstuteAnalytica India Pvt. Ltd.
Analysts on Coloplast's financial targets: Well suited for a new CEO
Sep 2, 2025 • medwatch.com
Coloplast shares gain on updated mid-term guidance
Sep 2, 2025 • Investing.com
Coloplast launches new strategy – expects sales growth of 7-8%
Sep 2, 2025 • medwatch.com
Coloplast A/S - Coloplast presents new 5-year strategy, Impact4
Sep 2, 2025 • Coloplast A/S
Coloplast announces new financial targets
Sep 2, 2025 • MarketScreener
Kerecis Fish-Skin Technology to Make a Splash at SAWC Fall 2025
Sep 2, 2025 • Business Wire
Coloplast A/S - Announcement no. 07/2025 - Coloplast announces new financial ambition towards 2030
Sep 2, 2025 • BioSpace
Coloplast Unveils New Long-Term Financial Targets
Sep 2, 2025 • MarketScreener
Coloplast A/S - Announcement no. 07/2025 - Coloplast announces new financial ambition towards 2030
Sep 2, 2025 • Coloplast A/S
Kerecis Fish-Skin Technology to Make a Splash at SAWC Fall 2025
Sep 2, 2025 • PharmiWeb
Coloplast presents new 5-year strategy, Impact4
Sep 2, 2025 • MarketScreener
Coloplast Outlines Five-year Organic Revenue Growth Target
Sep 2, 2025 • MarketScreener
Coloplast A/S - Announcement no. 07/2025 - Coloplast announces new financial ambition towards 2030
Sep 1, 2025 • Yahoo Finance
Dutch-Danish alliance expected to shape sustainable health policies
Aug 25, 2025 • EURACTIV
Coloplast A/S Just Missed EPS By 16%: Here's What Analysts Think Will Happen Next
Aug 22, 2025 • simplywall.st
Coloplast stock price target raised to DKK710 from DKK700 at RBC
Aug 22, 2025 • Investing.com
Coloplast price target raised by DKK 10 at RBC Capital
Aug 22, 2025 • thefly.com
RBC Updates Coloplast Price Target, Earnings Estimates Ahead of Capital Markets Day
Aug 22, 2025 • MarketScreener
Boston Scientific Obtryx Litigation Update
Aug 21, 2025 • EIN Presswire
Coloplast AS (CLPBF) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amidst Challenges
Aug 20, 2025 • Yahoo Finance
Lars Rasmussen reveals Coloplast's focus areas: Customers and innovation in focus in new five-year plan
Aug 20, 2025 • medwatch.com
Coloplast price target lowered by DKK 15 at Morgan Stanley
Aug 20, 2025 • thefly.com
Hydrogel Dressing Market Poised for Transformative Growth with Rising Demand in Advanced Wound Care Solutions 2025
Aug 20, 2025 • EIN Presswire
Coloplast A/S – Updated presenters list for Capital Markets Day on 2 September 2025
Aug 19, 2025 • Yahoo Finance
Coloplast' Q3 earnings underperform analyst forecast
Aug 19, 2025 • medwatch.com
Coloplast A/S – Updated presenters list for Capital Markets Day on 2 September 2025
Aug 19, 2025 • Coloplast A/S
Coloplast A/S - Announcement no. 05/2025 - Coloplast announces changes to Executive Leadership Team
Aug 19, 2025 • BioSpace
Corporate results schedule for August 19, 2025
Aug 19, 2025 • MarketScreener
Coloplast reports solid Q3 with 6.6% organic sales growth
Aug 19, 2025 • Investing.com
Coloplast Announces Leadership Changes and New Organizational Structure
Aug 19, 2025 • MarketScreener
Coloplast A/S - Announcement no. 05/2025 - Coloplast announces changes to Executive Leadership Team
Aug 19, 2025 • Coloplast A/S
European stocks edge higher after Washington meeting; defence stocks retreat
Aug 19, 2025 • Investing.com
Wound Gel Market Size to Exceed USD 9.09 Billion by 2032, Driven by Growing Geriatric Population | SNS Insider
Aug 19, 2025 • SNS Insider pvt ltd
Coloplast A/S - Interim Financial Report, 9M 2024/25
Aug 18, 2025 • Yahoo Finance
Prelude to Coloplast's quarterly results: Slight progress expected while US tariffs remain a key issue
Aug 18, 2025 • medwatch.com
Urinary Incontinence Devices Market Poised to Surge from USD 2,098.65 million in 2025 to USD 6,179.32 Million by 2030
Aug 13, 2025 • EIN Presswire
Wound Care Management Devices Market Poised to Growth USD 30.0 Billion by 2035 with Thriving CAGR of 4.21%
Aug 13, 2025 • EIN Presswire
Coloplast A/S - 9M 2024/25 Earnings Release - Invitation to conference call on 19 August 2025 at 11.00am CEST
Aug 8, 2025 • Yahoo! Finance UK
Coloplast A/S - 9M 2024/25 Earnings Release - Invitation to conference call on 19 August 2025 at 11.00am CEST
Aug 8, 2025 • Coloplast A/S
Erectile Dysfunction Devices Market to Surpass 6.32 Billion USD by 2032 at 9.5% CAGR Growth
Aug 6, 2025 • EIN Presswire
Pressure Ulcers Treatment Market Report 2025-2034: Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape
Aug 4, 2025 • Research and Markets
Coloplast (CPH:COLO B) investors are sitting on a loss of 36% if they invested five years ago
Aug 1, 2025 • simplywall.st
Global Urinary Drainage Bags Market: Growth Path, Drivers, and Future Potential (2021–2031)
Jul 30, 2025 • EIN Presswire
Regenerative Medicine Market to Reach Over USD 403.86 Billion by 2032 with Breakthrough Investments | DataM Intelligence
Jul 30, 2025 • EIN Presswire